Q2 FY2026 · ended Jun 30, 2026 · Revenue $23.03M, -35.0% YoY · Filed Aug 11, 2026
Xtant Medical Holdings, Inc. (XTNT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $23.0 million and a net loss of $9.4 million. Free cash flow was -$7.6 million. As of Jun 30, 2026 it held $9.9 million in cash and investments and $14.0 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- XTNT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Belgrade, MT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1453593
- Former names
- Bacterin International Holdings, Inc. (until Aug 3, 2015); K KITZ INC (until May 21, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $23.0M | $20.9M | $32.4M | $33.3M | $35.4M |
| Operating income | -$9.2M | -$2.9M | -$944,000 | $2.5M | $4.6M |
| Net income | -$9.4M | -$3.1M | $57,000 | $1.3M | $3.5M |
| Diluted EPS | -$0.07 | -$0.02 | $0.00 | $0.01 | $0.02 |
| Operating cash flow | -$7.3M | -$2.1M | $5.4M | $4.6M | $1.3M |
| Free cash flow | -$7.6M | -$2.3M | $5.0M | $4.2M | $910,000 |
| Total assets | $79.7M | $78.0M | $94.1M | $106.3M | $103.5M |
| Total liabilities | $39.7M | $29.4M | $43.2M | $55.9M | $55.0M |
| Stockholders' equity | $40.0M | $48.6M | $51.0M | $50.4M | $48.5M |
| Cash and investments | $9.9M | $12.1M | $17.1M | $10.4M | $6.9M |
| Total debt | $14.0M | $15.0M | $17.9M | $21.2M | $25.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 7, 2026 | Aug 7, 2026 |
| ARS | Annual report to shareholders | Jun 23, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2026 | May 13, 2026 |
All 1000 Xtant Medical Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.